Clinical trial
The Effects of ProFoveate on Reducing Self-Stimulating Behaviors in Children Diagnosed With Autism Spectrum Disorders
NCT02088047 is registered in ClinicalTrials.gov with University of Arkansas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of ProFoveate on Reducing Self-Stimulating Behaviors in Children Diagnosed With Autism Spectrum Disorders
- Lead sponsor
- University of Arkansas
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- August 30, 2014
- Completion date
- October 4, 2018
- Enrollment
- 4 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
autism spectrum disorders, exhibit self- stimulating or ritualistic behaviors, normal hearing, normal intelligence